@prefix ns1: <http://schema.org/> .

{
    <http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=206575> a ns1:MedicalCondition ;
        ns1:alternateName "Acquired rippling muscle disease",
            "Immune-mediated rippling muscle disease" ;
        ns1:code [ a ns1:MedicalCode ;
                ns1:codeValue "ORPHA:206575" ;
                ns1:codingSystem "ORPHAcode" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "G70.8" ;
                ns1:codingSystem "ICD-10" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "G70.8" ;
                ns1:codingSystem "ICD-10" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "ORPHA:206575" ;
                ns1:codingSystem "ORPHAcode" ] ;
        ns1:description "Rippling muscle disease with myasthenia gravis is a rare, acquired, neuromuscular disease characterized by <i>CAV3</i> mutation-negative rippling muscle disease in association with acetylcholine receptor antibody-mediated myasthenia gravis. Patients typically present exercise-induced, electrically-silent muscle rippling with myalgia, in combination with generalized myasthenia gravis symptoms (ptosis, diplopia, neck weakness, dysphagia and dyspnea)." ;
        ns1:epidemiology "Prevalence : " ;
        ns1:identifier "206575" ;
        ns1:name [ a ns1:PronounceableText ;
                ns1:inLanguage "EN" ;
                ns1:textValue "Rippling muscle disease with myasthenia gravis" ],
            [ a ns1:PronounceableText ;
                ns1:inLanguage "EN" ;
                ns1:textValue "Rippling muscle disease with myasthenia gravis" ] .
}

